Physician Assistant · Whiteville, NC
NPI
1013139096
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
619 Jefferson St
Whiteville, NC, 28472
Phone (910) 642-0331
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
1,853 services
Medicare patients, 2024
261
Average age 73
Drug cost, 2024
$2.5M
26,062 prescriptions
Company payments, 2025
$689
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey A Clarke was code 99214 (office e&m - established), 556 times for 247 patients. In total Jeffrey A Clarke billed 1,853 services in 28 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 556 | 247 | $64.96 | $36K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 254 | 52 | $0.08 | $20.83 |
| 96372 Injection Administration | Office | 240 | 88 | $8.29 | $1,990 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 192 | 40 | $0.67 | $128 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 135 | 47 | $4.84 | $653 |
| G0008 Administration of influenza virus vaccine | Office | 79 | 75 | $30.01 | $2,370 |
| 90662 Vaccine Product | Office | 71 | 68 | $80.57 | $5,720 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 64 | 14 | $0.24 | $15.43 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 61 | 61 | $107.96 | $6,586 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 58 | 21 | $0.95 | $54.91 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 49 | 13 | $0.33 | $16.12 |
| 20610 Joint Injection | Office | 18 | 17 | $29.95 | $539 |
| 93000 Electrocardiogram | Office | 17 | 15 | $8.26 | $140 |
| 99215 Office E&M - Established | Office | 16 | 14 | $99.39 | $1,590 |
| 99213 Office E&M - Established | Office | 14 | 14 | $47.21 | $661 |
By year: 2022 $88K for 2,710 services; 2023 $71K for 2,111 services; 2024 $58K for 1,853 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 21 | 21 | $33.50 | $703 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey A Clarke prescribed most often to Medicare patients was Levothyroxine Sodium, with 791 prescriptions and refills. In total Jeffrey A Clarke wrote 26,062 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 791 | 1,919 | 182 | $6,738 |
| Atorvastatin Calcium Generic | 766 | 1,949 | 193 | $6,256 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 714 | 714 | 110 | $18K |
| Gabapentin Generic | 693 | 1,228 | 158 | $13K |
| Potassium Chloride Generic | 634 | 1,400 | 157 | $9,686 |
| Pantoprazole Sodium Generic | 576 | 1,284 | 142 | $4,563 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 559 | 559 | 63 | $18K |
| Furosemide Generic | 541 | 1,202 | 150 | $2,384 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 529 | 570 | 110 | $14K |
| Amlodipine Besylate Generic | 515 | 1,126 | 118 | $2,288 |
| Omeprazole Generic | 489 | 1,112 | 116 | $5,992 |
| Oxycodone Hcl Generic | 427 | 427 | 67 | $7,609 |
| Metoprolol Succinate Generic | 366 | 960 | 106 | $3,631 |
| Levocetirizine Dihydrochloride Generic | 340 | 884 | 109 | $3,711 |
| Fluticasone Propionate Generic | 336 | 539 | 92 | $4,131 |
Brand drugs: 3,308 claims; generic drugs: 22,581 claims; opioid claims: 2,005.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey A Clarke $689 ($689 in general payments such as food, travel and fees) from 16 companies. The largest payer was Pfizer Inc. with $117.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 6 | $117 |
| Abbott Laboratories ABT | 5 | $91.06 |
| Novo Nordisk Inc NVO | 5 | $85.78 |
| Abbvie Inc. ABBV | 4 | $66.33 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $64.68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $46.13 |
| Amgen Inc. AMGN | 3 | $44.06 |
| GlaxoSmithKline, LLC. GSK | 3 | $41.49 |
| Inspire Medical Systems, Inc. INSP | 1 | $23.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $19.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.